RA
EHC icon

Rise Advisors’s Encompass Health EHC Stock Holding History

Rise Advisors’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-173
Closed -$21.9K – 508
2025
Q3 		$21.9K Buy
173
+1
+0.6% +$119 0.01% 527
2025
Q2 		$21.1K Hold
172
– – 0.01% 503
2025
Q1 		$17.4K Sell
172
-113
-40% -$11K 0.01% 592
2024
Q4 		$26.3K Buy
285
+1
+0.4% +$98 0.01% 468
2024
Q3 		$27.4K Hold
284
– – 0.01% 462
2024
Q2 		$24.3K Buy
284
+1
+0.4% +$84 0.01% 492
2024
Q1 		$23.4K Buy
+283
New +$20.7K 0.01% 541

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Rise Advisors's EHC Position: Q4 2025 in Review

Rise Advisors sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 173 shares — an estimated $21.9K sold.

Rise Advisors first reported a position in EHC in Q1 2024 and held it in 7 quarters. The position peaked at $27.4K in Q3 2024. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Rise Advisors reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 173 Encompass Health shares in Q4 2025, an estimated $21.9K.
  • Rise Advisors first reported a position in Encompass Health in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Encompass Health position peaked at $27.4K in Q3 2024.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.